Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,227,322
-$538,908 QoQ
Shares Held
134,025
-0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#774
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARCO INVESTMENT MANAGEMENT LLC holds $82,947,226 across 10 Drug Manufacturers - General names. PFE ranks #5 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
139,569 | $35,121,143 | |
| 2 | AMGN |
Amgen Inc
|
43,180 | $15,636,341 | |
| 3 | MRK |
Merck & Co., Inc.
|
95,255 | $12,240,267 | |
| 4 | JNJ |
Johnson & Johnson
|
28,817 | $7,318,653 | |
| 5 | PFE |
Pfizer Inc
This page
|
134,025 | $3,227,322 | |
| 6 | LLY |
ELI LILLY & Co
|
2,149 | $2,577,575 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
19,101 | $2,413,220 | |
| 8 | NVS |
Novartis AG
|
13,875 | $2,174,490 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,227,322 | 134,025 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,766,230 | 134,125 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,448,874 | 138,509 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $3,521,565 | 138,209 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,357,458 | 138,509 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,731,897 | 147,273 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,887,493 | 146,532 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,295,622 | 148,432 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,010,429 | 143,332 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $3,796,477 | 136,810 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,908,530 | 135,760 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,573,081 | 137,868 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $5,177,235 | 141,146 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,118,735 | 149,969 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,040,478 | 156,918 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,832,336 | 156,132 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,234,970 | 157,066 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,678,733 | 148,324 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $8,841,084 | 149,722 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,420,833 | 149,287 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,903,839 | 150,762 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,284,290 | 145,854 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $4,722,134 | 128,284 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,549,878 | 123,975 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $3,728,457 | 114,020 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $3,799,911 | 116,419 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||